Skip to search.
 TSX Down 0.24% TSX Ventures Down 0.21%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
1.58 0.00(0.00%) Jan 13, 4:00PM EST
Prev Close:1.58
Open:1.59
Bid:0.44 x 100
Ask:1.64 x 100
1y Target Est:4.00
Beta:2.07418
Earnings Date:Mar 8 - Mar 13 (Est.)
Day's Range:1.56 - 1.64
52wk Range:1.19 - 3.33
Volume:730,597
Avg Vol (3m):1,114,590
Market Cap:233.29M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
IDRA 0.00%233.29M
PFEDown 0.25%197.34B
DVAX 0.00%167.60M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):210.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.42
Quarterly EPS Est (Dec-16) :-0.11
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback